Colossa Ventures Research
Investment Thesis
Colossa Ventures is a Mumbai-based venture capital firm, founded in 2022, built around a "WomenFirst" investment thesis. The firm's core belief is that women make up roughly 50% of India's population, drive more than 75% of household purchasing decisions, and have demonstrated success rates as founders comparable to men, yet remain significantly underfunded and under-mentored. Colossa backs startups where women are either the primary beneficiaries of the product or the founders/leaders of the business, and frames its value-add around a "3C Framework": Capital (early-stage equity and follow-on financing access), Capability (mentorship, training, and market linkages via partnerships with institutions like IIT Bombay and IIT Madras), and Confidence (community-building support to help women founders overcome structural bias).
Sector Focus
The firm invests across five primary sectors: SaaS & Deep Tech, Fintech, Healthcare/Healthtech, Climate & Cleantech, and Consumer. Its actual portfolio reflects this breadth, spanning fabless semiconductors (Morphing Machines), fintech credit infrastructure (FinReach), biotech/skin therapeutics (Ahammune Biosciences, Serigen Mediproducts), water and air filtration cleantech (Exposome), electric two-wheelers (Vioma Motors), consumer/FMCG marketplaces (Meolaa, FS Life), and edtech teacher accreditation (CENTA).
Stage Focus
Colossa invests primarily at the Pre-Series A stage and beyond, positioning itself as an early institutional check for women-led or women-focused startups that have moved past pure seed risk but are still building toward Series A metrics.
Check Size
The firm's public materials do not disclose a specific check-size range. Observed round sizes it has participated in span roughly INR 10-23 crore (~$1.2M-$2.8M) at the round level, with Colossa as either lead or a syndicate participant, so individual check sizes are likely a fraction of that.
Lead Tendency
Colossa has both led and followed in its recent deals. It led the Pre-Series A round in Exposome (October 2025) and led the seed round in FinReach Solutions (November 2025), but was a syndicate participant (not lead) in Meolaa's pre-Series A round led by General Catalyst (October 2025).
Recent Activity
The firm's vehicle for this strategy, the Colossa WomenFirst Fund (AIF Category II, SEBI registration IN/AIF2/22-23/1245), announced its first close of INR 100 crore (~$12M) in March 2024 against a target corpus of INR 500 crore, with anchor commitments from SIDBI, Dr. Ranjan Pai's family office, and the Shriram Ownership Trust. As of its most recent reported activity, the fund has made 9 disclosed investments, with at least 2 in the trailing 12 months (Exposome and FinReach both closed in Q4 2025), indicating the fund is actively deploying.
Portfolio Highlights
Notable portfolio companies include Morphing Machines (reconfigurable embedded processor IP, deep tech), FinReach (MSME credit/risk-tech, raised INR 21.9 crore led by Colossa in Nov 2025), Exposome (industrial water/air filtration cleantech, raised INR 23 crore Pre-Series A led by Colossa in Oct 2025), Meolaa (AI-first FMCG marketplace, raised $6M pre-Series A led by General Catalyst with Colossa participating in Oct 2025), Ahammune Biosciences (small-molecule skin therapeutics), Serigen Mediproducts (tissue regeneration), CENTA (teacher accreditation edtech), FS Life (women's apparel), and Vioma Motors (electric two-wheelers).
Team
- Ashu Suyash, Founder & CEO — former MD & CEO of CRISIL, ex-India Country Head at Fidelity International, ex-Citibanker, Chartered Accountant
- Vandana Rajadhyaksha, Founder & Co-Head — ex-Partner at ICICI Ventures and Aditya Birla Private Equity, 21+ years in venture capital and private equity
- Rajesh Krishnamoorthy, Senior Venture Partner
- Dr. Rishika Agarwal, Venture Partner — biotech background
- Anuj Kokate, AVP — 6 years in financial services
- Khush Trivedi, Research Associate — 3 years experience
- Vidhi Dalmia, Associate — MBBS, healthtech background
- Dev Parekh, Analyst — IIT Bombay graduate
- Divyani Gaikwad, Manager, Finance and Compliance
- Uthara Iyer — deep tech investing and consulting background
The firm also maintains an advisory board including Farida Khambata (Co-founder Cartica, ex-Regional Head IFC), Harinarayan Sharma (CEO, Manipal Foundation), Raghu Cavale (former Head India Business, Infosys), Ruchi Kalra (Co-founder OfBusiness & Oxyzo), Shantanu Deshpande (Founder, Bombay Shaving Company), and Shrestha Chowdhury (Co-Founder & CTO, Razor Group Germany).
Decision Process
Colossa is structured as a two-founder partnership (Suyash and Rajadhyaksha) supported by a team of venture partners, associates, and analysts, plus an external advisory board. This points to a partnership-style decision process rather than a solo-GP model, though the exact decision-making mechanics are not publicly disclosed.
Founder Preferences
The firm's stated mandate is to back founders (of any gender) building products where women are the primary beneficiaries, or to back women founders/leaders directly, across its five focus sectors. It emphasizes filling three gaps it sees underserved women-focused businesses facing: funding access, market linkages, and mentorship.
Geographic Focus
Colossa Ventures is headquartered in Mumbai (INNOV8, Tower B, Peninsula Business Park, Lower Parel) and invests exclusively in India-based startups.